Disrupted Redox Regulation and Inflammatory Response in Pyoderma Gangrenosum

Area of Science:

• Immunology
• Biochemistry
• Dermatology

Background:

• Pyoderma Gangrenosum (PG) pathophysiology involves complex immune dysregulation, including inflammation, altered redox signaling, and cytokine overexpression.
• Understanding the specific biochemical markers associated with PG is crucial for improving diagnosis and treatment.

Purpose of the Study:

• To investigate the role of inflammation, redox signaling, and immune markers in the pathogenesis of Pyoderma Gangrenosum.
• To compare serum concentrations of specific biochemical markers between PG patients and healthy controls.
• To evaluate the changes in these markers before and after treatment in PG patients.

Main Methods:

• A case-control study involving 36 PG patients and 30 controls.
• Serum analysis of acute phase proteins (CRP, AGPA, Albumin), IL-17A, β2MG, and glutathione system (GSH, GSSG, GSH/GSSG ratio).
• Assessment of hematological parameters including WBC, NLR, and ESR, with pre- and post-treatment evaluations in PG patients.

Main Results:

• Significant differences in serum concentrations of acute phase proteins, IL-17A, β2MG, and the glutathione system were observed between PG patients and controls.
• PG patients exhibited an exaggerated and persistent inflammatory response, indicated by elevated WBC, NLR, ESR, CRP, AGPA, Albumin, and IL-17A.
• Biochemical dysregulation was more severe in PG patients with associated systemic diseases.

Conclusions:

• The study highlights an imbalance in acute phase proteins, β2MG-MHC class I complex, and the GSH-GSSG system in Pyoderma Gangrenosum.
• These findings contribute to a better understanding of PG's pathogenic basis.
• The identified markers may aid in improving the diagnosis of Pyoderma Gangrenosum.